The spotlights are on lab-on-a-chip technology these days. Understandable, because many solutions concerning COVID-19 revolve around this technology. Labs-on-chips not only play a vital part in the tests that point out whether someone is infected with the virus, but also in the process of unravelling the genetic code of the virus in order to develop a vaccine.
The underlying technology for labs-on-chips is microfluidics. It is indispensable in procedures such as DNA sequencing and single cell analysis and it forms the basis of point-of-care products that enable the decentralization of diagnostics.
In the coming weeks, our experts will be available to share their knowledge about this vital technology with you. They will appear in three different webinars. Each webinar has its own focal point, but they all give an outlook on the possibilities of microfluidics in biomedical procedures. The duration of each webinar will be about 45-60 minutes.
We warmly invite you to attend one or all of the following webinars:
- 'Using microfluidic technologies for DNA sequencing and single-cell analysis' - by Dr. Mark Olde Riekerink
- 'Using microfluidic technologies for Point-of-Care diagnostics' - by Dr. Monica Brivio
- 'Let's make droplets!' - by Erik Linnartz